MedTrace Logo

Hematological Manifestations in Systemic Lupus Erythematosus Patients

NCT06936007 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2025-04-20

No results posted yet for this study

Summary

The goal of this observational study is to evaluate hematological abnormalities among patients with systemic lupus erythematosus (SLE) admitted to a tertiary care center in Nepal. The main question it aims to answer is:

\- What are the types and frequencies of hematological abnormalities seen in hospitalized SLE patients in Nepal?

The study retrospectively reviews medical records of SLE patients admitted between April 2018 and March 2023 to collect data on hematologic parameters, demographic profiles, clinical manifestations.

Conditions

  • Systemic Lupus Erythematosus (SLE)

Sponsors & Collaborators

  • Patan Academy of Health Sciences

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06936007 on ClinicalTrials.gov